Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Thoughts on hot issues of neuromyelitis optica].
Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
Genomic medicine and risk prediction across the disease spectrum.
[Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica : Therapy option for acute relapses during pregnancy and breastfeeding.]
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.
Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Involvement of MeCP2 in Regulation of Myelin-Related Gene Expression in Cultured Rat Oligodendrocytes.
Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.
Association of Deep Gray Matter Damage With Cortical and Spinal Cord Degeneration in Primary Progressive Multiple Sclerosis.
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Atypical presentation of multiple sclerosis.
HINT1 peptide/Hsp70 complex induces NK cell-dependent immunoregulation in a model of autoimmune demyelination.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
[Evaluation of the autonomic regulation of the cardiac oxygen supply of measured physical activity in patients with remitting multiple sclerosis.]
Supine and upright urodynamic evaluation of incontinent ileovesicostomy in wheelchair-bound adults with neurogenic bladder.
[Alemtuzumab is a new drug based on monoclonal antibodies for treatment multiple sclerosis: treatment possibilities and risks(review)].
Health Authorities Data Collection of THC:CBD Oromucosal Spray (L'Agenzia Italiana del Farmaco Web Registry): Figures after 1.5 Years.
Neurodegeneration: From Multiple Sclerosis to Alzheimer's Disease.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Fulminant inflammatory demyelination: long-term course and magnetic resonance imaging findings.
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.
Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.

Pages